Phase 1/2 TRIDENT-1 study of repotrectinib in patients with ROS1+ or NTRK+ advanced solid tumors Meeting Abstract
| Authors: | Cho, B. C.; Doebele, R. C.; Lin, J.; Nagasaka, M.; Baik, C.; Van der Wekken, A.; Velcheti, V.; Lee, K. H.; Liu, S.; Solomon, B.; Kao, S.; Krebs, M. G.; Zhu, V.; Stopatschinskaja, S.; Camidge, R.; Drilon, A. |
| Abstract Title: | Phase 1/2 TRIDENT-1 study of repotrectinib in patients with ROS1+ or NTRK+ advanced solid tumors |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | repotrectinib tki-naive response |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S174 |
| End Page: | S175 |
| Language: | English |
| ACCESSION: | WOS:000631349600200 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.251 |
| Notes: | Meeting Abstract: MA11.07 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
